Warning letter
Aventis Bio-Services: warning letter of Jun 29, 2001
FDA warning letter UCM178170 · Atlanta District Office
Key facts
| Reference number | UCM178170 |
|---|---|
| Company | Aventis Bio-Services |
| Subject | Good Manufacturing Practices for Blood & Blood Components |
| Issue date | Jun 29, 2001 |
| Posted date | Jun 29, 2001 |
| Issuing office | Atlanta District Office |
| Product type | Unknown |
| CFR sections cited | 606.160, 606.100, 606.20(b) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: